All News

UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.

Computers have transformed our working lives. Now as they become pervasive elsewhere, leading experts call for an overhaul of research in human–computer interaction.

Financing high-tech start-ups is not getting any easier, but a pioneering UK biotech may have an escape route

Small is beautiful: patent applications are continuing to rise, but the European Patent Office is pleased that the number it grants is falling.